What if my insurance won't cover shockwave therapy for plantar fasciitis?

Most commercial insurance plans do not cover ESWT for plantar fasciitis, despite its FDA-cleared status for this indication. The total out-of-pocket cost typically ranges from $300 to $1,500 for a full treatment course. Many patients use FSA or HSA funds, which generally cover ESWT as a qualifying medical expense. Some providers offer payment plans.

Can I try shockwave therapy before completing six months of conservative treatment?

Most clinical guidelines recommend at least 6 months of conservative treatment before pursuing ESWT, because many cases of plantar fasciitis resolve on their own during this period. However, the decision is between you and your provider. Patients with severe symptoms that significantly limit daily function may be considered earlier in some clinical settings.

What happens if shockwave therapy doesn't work for my plantar fasciitis?

If ESWT does not produce meaningful improvement after 12 to 16 weeks, your provider should reassess the diagnosis (to rule out nerve entrapment, stress fracture, or other conditions), consider alternative treatments such as PRP injection, or discuss surgical options like plantar fascia release. Approximately 20 to 40% of patients do not respond adequately to ESWT.

Shockwave Therapy for Chronic Plantar Fasciitis

You’ve been dealing with heel pain for months. You’ve stretched your calves religiously, worn orthotics, iced after walking, and maybe even tried a cortisone injection or two. Some of those treatments helped – temporarily. But the pain keeps coming back, especially those first steps in the morning that feel like stepping on a nail.

At some point, you start wondering: is shockwave therapy the right next step? This is not a general overview of shockwave therapy for plantar fasciitis or a guide for people who just started experiencing heel pain. This is a decision-support article for the person who has been in treatment for a while and is weighing whether ESWT makes sense for them right now.

The Clinical Criteria Most Providers Use

Not every plantar fasciitis patient is a good candidate for shockwave therapy. Most providers apply a set of clinical criteria before recommending ESWT:

Duration of symptoms. The most commonly cited threshold is 6 months of persistent symptoms despite conservative treatment. This timeline reflects two realities: first, the majority of plantar fasciitis cases (80-90%) resolve with conservative measures within a year. Second, ESWT works best on chronic, degenerative tissue (tendinopathy) rather than acute inflammation. By 6 months, the tissue pathology has typically shifted from inflammatory to degenerative – which is exactly what shockwave therapy targets.

Failed conservative treatments. Most guidelines expect patients to have tried and failed at least 2 to 3 conservative approaches before pursuing ESWT. These typically include stretching and physical therapy, orthotic devices or supportive footwear, activity modification, cortisone injection, and night splints. “Failed” doesn’t necessarily mean zero improvement – it means the improvement was insufficient for the patient’s functional needs or didn’t last.

Confirmed diagnosis. Your provider should confirm that the pain is actually coming from the plantar fascia, not from other structures in the heel. This may involve imaging (ultrasound or MRI) to assess fascial thickness and rule out other pathology.

Factors That Predict Better Outcomes

Research suggests that certain patient characteristics are associated with better ESWT outcomes for plantar fasciitis:

Unilateral involvement. Patients with plantar fasciitis in one foot tend to respond better than those with bilateral (both feet) involvement.
Symptom duration of 6 to 24 months. Paradoxically, very long-standing cases (beyond 2 years) may respond less well than cases in the 6-to-24-month range.
Pain localized to the medial calcaneal tubercle. Classic insertion-point pain – right where the fascia attaches to the heel bone – is the presentation with the strongest evidence behind ESWT.
Higher baseline pain. Patients with moderate-to-severe pain at baseline tend to show larger absolute improvements than those with mild symptoms.
Commitment to post-treatment rehabilitation. Patients who maintain stretching and progressive loading exercises during and after ESWT treatment tend to have better outcomes (Gerdesmeyer et al., 2008, American Journal of Sports Medicine).

Factors That Predict Worse Outcomes

Equally important are the factors associated with poorer response:

Bilateral plantar fasciitis. Having both feet affected suggests a systemic or biomechanical component that shockwave therapy alone may not fully address.
Elevated BMI. While ESWT can help patients across a range of body weights, higher BMI places ongoing mechanical stress on the plantar fascia that may limit treatment durability.
Unrealistic expectations. Patients expecting complete pain elimination rather than meaningful reduction are more likely to be disappointed. Clinical studies typically define success as 50% or greater reduction in pain – not zero pain.
Systemic conditions. Diabetes, peripheral neuropathy, and inflammatory arthritis can complicate healing and reduce ESWT effectiveness.
Concurrent use of fluoroquinolone antibiotics. This antibiotic class (ciprofloxacin, levofloxacin) is associated with tendon damage and may interfere with the healing response ESWT is designed to stimulate.

The Cost Decision

For most patients, ESWT for plantar fasciitis is an out-of-pocket expense. Understanding the financial picture is part of the decision:

Total treatment cost: $300 to $1,500 for a complete course of 3 to 5 sessions
Insurance status: Despite FDA clearance for plantar fasciitis, most commercial plans do not cover ESWT. Some plans cover it with prior authorization.
Alternative cost comparison: Ongoing conservative treatment (PT visits, orthotics, cortisone injections) can accumulate costs over months. Plantar fascia release surgery typically costs $5,000 to $15,000 including recovery.

For a comprehensive breakdown, see our guide on shockwave therapy costs and insurance coverage.

A Decision Framework

Here is a practical framework to help you and your provider evaluate whether ESWT is right for you right now:

Consider ESWT if:

Your symptoms have persisted 6+ months
You’ve tried at least 2-3 conservative treatments without lasting relief
Your diagnosis has been confirmed (ideally with imaging)
You’re willing to commit to the full treatment course (3-5 sessions over 3-6 weeks)
You’ll continue stretching and strengthening exercises during and after treatment
You accept that results develop gradually over 4-12 weeks after treatment

Consider other options first if:

You haven’t yet tried a structured stretching and PT program for at least 8-12 weeks
Your symptoms are less than 6 months old and still improving with current treatment
Your pain is mild and doesn’t significantly limit your daily activities
You haven’t been evaluated with imaging to confirm the diagnosis

Consider alternatives to ESWT if:

You’ve had symptoms for more than 2 years without any treatment response (the diagnosis should be re-evaluated)
You have a complete plantar fascia tear on imaging (surgical evaluation may be appropriate)
You have bilateral involvement plus systemic inflammatory disease (the root cause may need different treatment)

Finding the right provider matters. Look for a clinician who performs a thorough evaluation before recommending ESWT – not one who sells treatment packages without confirming that you’re an appropriate candidate. Providers offer ESWT with varying levels of expertise in plantar fasciitis specifically.

The Bottom Line

Shockwave therapy for chronic plantar fasciitis is a well-studied, non-invasive option for patients who have given conservative treatment a genuine effort without adequate relief. The best candidates have had symptoms for at least 6 months, have tried and failed multiple conservative approaches, have a confirmed diagnosis, and hold realistic expectations. It is not a first-line treatment, and it is not right for every patient – but for the right candidate at the right time, the evidence supports it as a reasonable step before considering surgery.

References

Schmitz C, Császár NB, Milz S, et al. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database. Br J Sports Med. 2015;49(9):590-595. PubMed

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Shockwave therapy outcomes vary by individual and condition. Consult a qualified healthcare provider to determine if shockwave therapy is appropriate for your situation.